Tinkeso Therapeutics Inc.
Valhalla, NY
- UEI
- UBBAK1VKK8H9
- CAGE
- 7LA88
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 40 Sunshine Cottage Rd, Valhalla, NY 10595, USA
- Website
- tinkeso.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Chimeric antigen receptor-modified inkt cell therapy for CD7+ malignancies | National Cancer Institute (NIH) | $748,619 |
Quick answers
Is Tinkeso Therapeutics Inc. registered in SAM.gov?
Yes. Tinkeso Therapeutics Inc.'s SAM.gov registration is active through September 7, 2027.
What is Tinkeso Therapeutics Inc.'s most recent federal award?
Tinkeso Therapeutics Inc.'s most recent federal grant award is Chimeric antigen receptor-modified inkt cell therapy for CD7+ malignancies (R43CA277958), from National Cancer Institute (NIH), on July 1, 2023.
On GovTribe
See Tinkeso Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors